Liquidia Corp (LQDA) Earnings Call Presentation
©2025 LIQUIDIA CORPORATION ALL RIGHTS RESERVED 2 Now FDA Approved FDA Approval YUTREPIA (treprostinil) inhalation powder Investor Call May 27, 2025 ©2025 LIQUIDIA CORPORATION ALL RIGHTS RESERVED Forward-looking statements This presentation includes, and our response to questions may include, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). All statements contained in this presentation other than statements of historical facts, including stateme ...